M. Sobol

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.

S. Pinder, H. Earl, D. Rea, 2016, Journal of the National Cancer Institute.

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

J. Lubiński, S. Narod, M. Sobol, 2016, Hereditary Cancer in Clinical Practice.

Evaluation of multiple transcriptomic gene risk signatures in male breast cancer

E. Winer, O. Bogler, I. Hedenfalk, 2021, NPJ breast cancer.

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

J. Lubiński, M. Sobol, T. Byrski, 2016, Hereditary Cancer in Clinical Practice.

Evaluation of multiple transcriptomic gene risk signatures in male breast cancer

O. Bogler, I. Hedenfalk, P. Porter, 2021, npj Breast Cancer.

Abstract P4-11-07: Comparison of multiparameter tests in the UK OPTIMA-Prelim trial

J. Donovan, S. Pinder, A. Makris, 2015 .

Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer

J. Donovan, S. Pinder, H. Earl, 2015 .